Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Mukai

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
American Journal of Ophthalmology|April 6, 2018
Peripheral Changes Associated With Delayed Dark Adaptation in Age-related Macular DegenerationInês Laíns, Dong Ho Park, Ryo Mukai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2018
Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachmentYoko Okunuki, Ryo Mukai, Elizabeth A Pearsall, et al.
Neurobiology of Disease|September 26, 2025
The alternative complement pathway drives neuroinflammation and neurodegeneration in mouse models of glaucoma and optic nerve injuryCindy Hoppe, Ryo Mukai, Nasrin Refaian, et al.
Experimental Eye Research|September 25, 2021
Broad locations of antigenic regions for anti-TRPM1 autoantibodies in paraneoplastic retinopathy with retinal ON bipolar cell dysfunctionDaichi Gyoten, Shinji Ueno, Satoshi Okado, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 13, 2025
Treatment outcomes of switching to aflibercept 8 mg in previously-treated neovascular age-related macular degenerationKeiko Kataoka, Koji Tanaka, Junichiro Honjyo, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 5, 2023
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degenerationKeiko Kataoka, Kanako Itagaki, Nozumu Hashiya, et al.
Scientific Reports|May 22, 2024
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in JapanRyo Mukai, Keiko Kataoka, Koji Tanaka, et al.
Scientific Reports|May 30, 2023
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in JapanRyo Mukai, Keiko Kataoka, Koji Tanaka, et al.
Retina (Philadelphia, Pa.)|November 28, 2023
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration StudySatoru Inoda, Hidenori Takahashi, Maiko Maruyama-Inoue, et al.
Scientific Reports|August 25, 2017
A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degenerationKenji Yamashiro, Keisuke Mori, Shigeru Honda, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
American Journal of Ophthalmology|April 6, 2018
Peripheral Changes Associated With Delayed Dark Adaptation in Age-related Macular DegenerationInês Laíns, Dong Ho Park, Ryo Mukai, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2018
Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachmentYoko Okunuki, Ryo Mukai, Elizabeth A Pearsall, et al.
Neurobiology of Disease|September 26, 2025
The alternative complement pathway drives neuroinflammation and neurodegeneration in mouse models of glaucoma and optic nerve injuryCindy Hoppe, Ryo Mukai, Nasrin Refaian, et al.
Experimental Eye Research|September 25, 2021
Broad locations of antigenic regions for anti-TRPM1 autoantibodies in paraneoplastic retinopathy with retinal ON bipolar cell dysfunctionDaichi Gyoten, Shinji Ueno, Satoshi Okado, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 13, 2025
Treatment outcomes of switching to aflibercept 8 mg in previously-treated neovascular age-related macular degenerationKeiko Kataoka, Koji Tanaka, Junichiro Honjyo, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 5, 2023
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degenerationKeiko Kataoka, Kanako Itagaki, Nozumu Hashiya, et al.
Scientific Reports|May 22, 2024
One-year outcomes and safety assessment of faricimab in treatment-naïve patients with neovascular age-related macular degeneration in JapanRyo Mukai, Keiko Kataoka, Koji Tanaka, et al.
Scientific Reports|May 30, 2023
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in JapanRyo Mukai, Keiko Kataoka, Koji Tanaka, et al.
Retina (Philadelphia, Pa.)|November 28, 2023
INCIDENCE AND RISK FACTORS OF INTRAOCULAR INFLAMMATION AFTER BROLUCIZUMAB TREATMENT IN JAPAN: A Multicenter Age-Related Macular Degeneration StudySatoru Inoda, Hidenori Takahashi, Maiko Maruyama-Inoue, et al.
Scientific Reports|August 25, 2017
A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degenerationKenji Yamashiro, Keisuke Mori, Shigeru Honda, et al.
Pageof 8